Overview

A SHR0302 BA Study on Healthy Subjects

Status:
COMPLETED

Trial end date:
2024-02-21

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate and compare the pharmacokinetics of SHR0302 two different kind tablets in Healthy subjects after administration two kind tablets (quick release tablets and sustained-release tablets).

Phase:

PHASE1

Details

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.